Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,411
Crownlands Observing Progression With Neurons Study
for
Alzheimer s Disease, Mild Cognitive Impairment (MCI)
Location: Germantown MD
Sponsor: Crownlands
Sex: All
Age: 55+
Code: NCT07611396
Recruiting
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
for
Aging
Location: Baltimore MD
Sponsor: National Institute on Aging (NIA)
Sex: All
Age: 55 - 70+
Code: NCT07099053
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Baltimore MD, Philadelphia PA, Pittsburgh PA,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
for
Femoral Neck Fractures
Location: Fairfax VA, Largo MD, Baltimore MD, Allentown PA,
Sponsor: University of Southern California
Sex: All
Age: 60+
Code: NCT07244211
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Chevy Chase MD, Philadelphia PA, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Chevy Chase MD, Philadelphia PA, Roanoke VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase3, Recruiting
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase3, Recruiting
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
for
Prostate Cancer
Location: Baltimore MD, New York NY, Seattle WA
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 18+
Code: NCT04995198
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
for
Hidradenitis Suppurativa (HS)
Location: Baltimore MD, Richmond VA, Plymouth Meeting PA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06855498
Phase3, Recruiting
Synbiotic Compound to Reduce Symptoms of Schizophrenia
for
Schizophrenia, Schizoaffective Disorder
Location: Batlimore MD
Sponsor: Sheppard Pratt Health System
Sex: All
Age: 18 - 65
Code: NCT04226898
Phase2, Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Baltimore MD, The Bronx NY, New Haven CT, Columbus OH,
Sponsor: DynamiCure Biotechnology
Sex: All
Age: 18+
Code: NCT05785754
Phase1, Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis